Sally Mossman, VP, Vaccines R&D and Head Discovery Performance Unit at GSK, joins BioTalk to discuss their Rockville location, why the BioHealth Capital Region is right for the GSK, and their role in the development of a COVID-19 Vaccine.
Information
- Show
- FrequencyUpdated Weekly
- PublishedSeptember 21, 2020 at 4:00 AM UTC
- Length30 min
- Episode65
- RatingClean